Alleviating Promotion of Inflammation and Cancer Induced by Nonsteroidal Anti-Inflammatory Drugs

Chen, Y. J. (2013). Studies on the pathological mechanisms and therapy ofinflammation and advanced glycation end products on chondrocytes [doctoral dissertation, National Taiwan University]. Airiti Library. https://doi.org/10.6342/NTU.2013.11069
Su, W. H., Cheng, M. H., Lee, W. L., Tsou, T. S., Chang, W. H., Chen, C. S., & Wang, P. H. (2010). Nonsteroidal Anti-Inflammatory Drugs for Wounds: Pain Relief or Excessive Scar Formation?. Mediators of Inflammation, 2010(), 478-485. https://doi.org/10.1155/2010/413238
葉忍莉、陸重隆（2001）。Gastrointestinal Medication Used in Terminal Cancer Patients。安寧療護雜誌，6(2)，27-31。https://doi.org/10.6537/TJHPC.2001.6(2).4
Mise, T., & Yasumoto, T. (2011). Simultaneous Treatment of Cancer Cells Lines with the Anticancer Drug Cisplatin and the Antioxidant Fucoxanthin. British Journal of Pharmacology and Toxicology, 2(3), 127-131. https://www.airitilibrary.com/Article/Detail?DocID=20442467-201108-201507070013-201507070013-127-131
Li, J., Li, H., & Ding, S. (2022). Pharmacological Action and Clinical Application of Commonly Used. International Journal of Social Science and Education Research, 5(7), 792-794. https://doi.org/10.6918/IJOSSER.202207_5(7).0119